Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on April 3, 2008

Stroke. 2008
Published online before print April 3, 2008, doi: 10.1161/STROKEAHA.107.506485
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/6/1735    most recent
STROKEAHA.107.506485v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Söderman, M.
Right arrow Articles by Andersson, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Söderman, M.
Right arrow Articles by Andersson, T.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Dementia
Related Collections
Right arrow Aneurysm, AVM, hematoma
Right arrow Acute Cerebral Hemorrhage
Right arrow Angiography
Right arrow Pathology of Stroke
Right arrow Primary and Secondary Stroke Prevention
Right arrow Risk Factors for Stroke

Submitted on October 7, 2007
Accepted on October 30, 2007

Natural History of Dural Arteriovenous Shunts

Michael Söderman MD, PhD*; Ladislav Pavic MD, PhD; Göran Edner MD; Staffan Holmin MD, PhD; and Tommy Andersson MD, PhD

From the Departments of Neuroradiology (M.S., S.H., T.A.), and Neurosurgery (G.E.), Karolinska University Hospital, Stockholm, Sweden; and the Department of Radiology (L.P.), University Hospital Dubrava, Zagreb, Croatia.

* To whom correspondence should be addressed. E-mail: michael.soderman{at}karolinska.se.

Background and Purpose—Dural arteriovenous shunts with cortical venous reflux or drainage may cause neurological symptoms and death with or without intracranial hemorrhage. Present knowledge about the natural history of these lesions is limited, however. We investigated the incidences of intracranial hemorrhage, progressive dementia syndrome, and death in patients diagnosed in our neurovascular center.

Methods—We evaluated the records of 85 patients with dural arteriovenous shunts with cortical venous drainage or reflux hospitalized in our institution from 1978 to 2007. The annual incidences of intracranial hemorrhage, progressive dementia syndrome, and death were calculated.

Results—Fifty-three patients did not have an intracranial hemorrhage as the presenting event. One of these patients bled after diagnosis. Thirty-two patients had an intracranial hemorrhage as the presenting event. Three patients bled after diagnosis. One of these patients died. Apart from deficits caused by hemorrhage, no patient reported adverse neurological symptoms. In patients presenting with an intracranial hemorrhage the annual risk for hemorrhage is approximately 7.4% and in those not presenting with a hemorrhage it is approximately 1.5%.

Conclusion—The risk of intracranial hemorrhage from a dural arteriovenous shunt with cortical venous drainage is most likely smaller than previously proposed. Presentation with hemorrhage is a risk factor for hemorrhage. The risks of developing neurological symptoms not related to hemorrhage are also less than previously reported.


Key words: dural arteriovenous fistula • dural arteriovenous shunts • hemorrhage • natural course • natural history